Ovarian steroids and the human breast: Regulation of stem cells and cell proliferation

Maturitas

Volumn 54, Issue 4, 2006, Pages 327-334

  Clarke, Robert B ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Breast; Paracrine signal; Proliferation; Stem cells; Steroid receptors

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR ALPHA; KI 67 ANTIGEN; PROGESTERONE; PROGESTERONE RECEPTOR; STEROID;

ARTICLE; BREAST CARCINOGENESIS; BREAST CELL; CELL FUNCTION; CELL LABELING; CELL PROLIFERATION; DISSOCIATION; ESTROGEN ACTIVITY; ESTROGEN BLOOD LEVEL; ESTROGEN SYNTHESIS; HORMONAL REGULATION; IMMUNOFLUORESCENCE TEST; MAMMARY GLAND; MOUSE STRAIN; NONHUMAN; NUDE MOUSE; PARACRINE SIGNALING; PROGESTERONE BLOOD LEVEL; PROGESTERONE SYNTHESIS; STEM CELL; XENOGRAFT;

ADULT STEM CELLS; ANIMALS; BREAST; CELL PROLIFERATION; EPITHELIAL CELLS; ESTROGENS; FEMALE; HUMANS; MICE; MICE, NUDE; MODELS, ANIMAL; OVARY; PROGESTERONE; RECEPTORS, STEROID; TRANSPLANTATION, HETEROLOGOUS;

MUS MUSCULUS;

EID: 33745685565     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2006.06.002     Document Type: Article

References (78)

1. Anderson E., Clarke R.B., and Howell A. Estrogen responsiveness and control of normal human breast proliferation. J Mammary Gland Biol Neoplasia 3 1 (1998) 23-35
2. Lambe M., Hsieh C.C., Chan H.W., Ekbom A., Trichopoulos D., and Adami H.O. Parity, age at first and last birth, and risk of breast cancer: a population-based study in Sweden. Breast Cancer Res Treat 38 3 (1996) 305-311
3. Staszewski J. Age at menarche and breast cancer. J Natl Cancer Inst 47 5 (1971) 935-940
4. Trichopoulos D., MacMahon B., and Cole P. Menopause and breast cancer risk. J Natl Cancer Inst 48 3 (1972) 605-613
5. Cohen S.M., and Ellwein L.B. Cell proliferation in carcinogenesis. Science 249 4972 (1990) 1007-1011
6. Cohen S.M., and Ellwein L.B. Genetic errors, cell proliferation, and carcinogenesis. Cancer Res 51 24 (1991) 6493-6505
7. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without the disease. Lancet 360 9328 (2002) 187-195
8. Key T.J., and Pike M.C. The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer. Eur J Cancer Clin Oncol 24 1 (1988) 29-43
9. Rajkumar L., Guzman R.C., Yang J., Thordarson G., Talamantes F., and Nandi S. Short-term exposure to pregnancy levels of estrogen prevents mammary carcinogenesis. Proc Natl Acad Sci USA 98 20 (2001) 11755-11759
10. Russo I.H., and Russo J. Role of hormones in mammary cancer initiation and progression. J Mammary Gland Biol Neoplasia 3 1 (1998) 49-61
11. Russo J., and Russo I.H. Development of the human mammary gland. In: Daniel C.W. (Ed). The mammary gland. Development, regulation and function (1987), Plenum Press, New York 67-93
12. Wellings S.R., Jensen H.M., and Marcum R.G. An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions. J Natl Cancer Inst 55 2 (1975) 231-273
13. Silberstein G.B., Van Horn K., Shyamala G., and Daniel C.W. Essential role of endogenous estrogen in directly stimulating mammary growth demonstrated by implants containing pure antiestrogens. Endocrinology 134 1 (1994) 84-90
14. Daniel C.W., Silberstein G.B., and Strickland P. Direct action of 17 beta-estradiol on mouse mammary ducts analyzed by sustained release implants and steroid autoradiography. Cancer Res 47 22 (1987) 6052-6057
15. Haslam S.Z. Progesterone effects on deoxyribonucleic acid synthesis in normal mouse mammary glands. Endocrinology 122 2 (1988) 464-470
16. Haslam S.Z. Local versus systemically mediated effects of estrogen on normal mammary epithelial cell deoxyribonucleic acid synthesis. Endocrinology 122 3 (1988) 860-867
17. Taylor-Papadimitriou J., Stampfer M., Bartek J., et al. Keratin expression in human mammary epithelial cells cultured from normal and malignant tissue: relation to in vivo phenotypes and influence of medium. J Cell Sci 94 (Pt 3) 22 (1989) 403-413
18. Mahendran R.S., O'Hare M.J., Ormerod M.G., Edwards P.A., McIlhinney R.A., and Gusterson B.A. A new monoclonal antibody to a cell-surface antigen that distinguishes luminal epithelial and myoepithelial cells in the rat mammary gland. J Cell Sci 94 (Pt 3) 2 (1989) 545-552
19. Gusterson B.A., Monaghan P., Mahendran R., Ellis J., and O'Hare M.J. Identification of myoepithelial cells in human and rat breasts by anti-common acute lymphoblastic leukemia antigen antibody A12. J Natl Cancer Inst 77 2 (1986) 343-349
20. Petersen O.W., Hoyer P.E., and van Deurs B. Frequency and distribution of estrogen receptor-positive cells in normal, nonlactating human breast tissue. Cancer Res 47 21 (1987) 5748-5751
21. Taylor-Papadimitriou J., Millis R., Burchell J., Nash R., Pang L., and Gilbert J. Patterns of reaction of monoclonal antibodies HMFG-1 and -2 with benign breast tissues and breast carcinomas. J Exp Pathol 2 4 (1986) 247-260
22. Perusinghe N.P., Monaghan P., O'Hare M.J., Ashley S., and Gusterson B.A. Effects of growth factors on proliferation on basal and luminal cells in human breast epithelial explants in serum-free culture. In Vitro Cell Dev Biol 28A 2 (1992) 90-96
23. Monaghan P., Perusinghe N.P., Nicholson R.I., et al. Growth factor stimulation of proliferating cell nuclear antigen (PCNA) in human breast epithelium in organ culture. Cell Biol Int Rep 15 7 (1991) 561-570
24. Abd El-Rehim D.M., Pinder S.E., Paish C.E., et al. Expression of luminal and basal cytokeratins in human breast carcinoma. J Pathol 203 2 (2004) 661-671
25. Santini D., Ceccarelli C., Taffurelli M., Pileri S., and Marrano D. Differentiation pathways in primary invasive breast carcinoma as suggested by intermediate filament and biopathological marker expression. J Pathol 179 4 (1996) 386-391
26. Anderson T.J., Ferguson D.J., and Raab G.M. Cell turnover in the "resting" human breast: influence of parity, contraceptive pill, age and laterality. Br J Cancer 46 3 (1982) 376-382
27. Battersby S., Robertson B.J., Anderson T.J., King R.J., and McPherson K. Influence of menstrual cycle, parity and oral contraceptive use on steroid hormone receptors in normal breast. Br J Cancer 65 4 (1992) 601-607
28. Ferguson D.J., and Anderson T.J. Morphological evaluation of cell turnover in relation to the menstrual cycle in the "resting" human breast. Br J Cancer 44 2 (1981) 177-181
29. Going J.J., Anderson T.J., Battersby S., and MacIntyre C.C. Proliferative and secretory activity in human breast during natural and artificial menstrual cycles. Am J Pathol 130 1 (1988) 193-204
30. Meyer J.S. Cell proliferation in normal human breast ducts, fibroadenomas, and other ductal hyperplasias measured by nuclear labeling with tritiated thymidine. Effects of menstrual phase, age, and oral contraceptive hormones. Hum Pathol 8 1 (1977) 67-81
31. Masters J.R., Drife J.O., and Scarisbrick J.J. Cyclic Variation of DNA synthesis in human breast epithelium. J Natl Cancer Inst 58 5 (1977) 1263-1265
32. Potten C.S., Watson R.J., Williams G.T., et al. The effect of age and menstrual cycle upon proliferative activity of the normal human breast. Br J Cancer 58 2 (1988) 163-170
33. Williams G., Anderson E., Howell A., et al. Oral contraceptive (OCP) use increases proliferation and decreases oestrogen receptor content of epithelial cells in the normal human breast. Int J Cancer 48 2 (1991) 206-210
34. Laidlaw I.J., Clarke R.B., Howell A., Owen A.W., Potten C.S., and Anderson E. The proliferation of normal human breast tissue implanted into athymic nude mice is stimulated by estrogen but not progesterone. Endocrinology 136 1 (1995) 164-171
35. Clarke R.B., Howell A., and Anderson E. Type I insulin-like growth factor receptor gene expression in normal human breast tissue treated with oestrogen and progesterone. Br J Cancer 75 2 (1997) 251-257
36. Clarke R.B., Howell A., and Anderson E. Estrogen sensitivity of normal human breast tissue in vivo and implanted into athymic nude mice: analysis of the relationship between estrogen-induced proliferation and progesterone receptor expression. Breast Cancer Res Treat 45 2 (1997) 121-133
37. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet 350 9084 (1997) 1047-1059
38. Writing group for the women's health initiative investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 288 3 (2002) 321-333
39. Magnusson C., Baron J.A., Correia N., Bergstrom R., Adami H.O., and Persson I. Breast-cancer risk following long-term oestrogen- and oestrogen-progestin-replacement therapy. Int J Cancer 81 3 (1999) 339-344
40. Ross R.K., Paganini-Hill A., Wan P.C., and Pike M.C. Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin. J Natl Cancer Inst 92 4 (2000) 328-332
41. Hargreaves D.F., Knox F., Swindell R., Potten C.S., and Bundred N.J. Epithelial proliferation and hormone receptor status in the normal post-menopausal breast and the effects of hormone replacement therapy. Br J Cancer 78 7 (1998) 945-949
42. Hofseth L.J., Raafat A.M., Osuch J.R., Pathak D.R., Slomski C.A., and Haslam S.Z. Hormone replacement therapy with estrogen or estrogen plus medroxyprogesterone acetate is associated with increased epithelial proliferation in the normal postmenopausal breast. J Clin Endocrinol Metab 84 12 (1999) 4559-4565
43. Catherino W.H., Jeng M.H., and Jordan V.C. Norgestrel and gestodene stimulate breast cancer cell growth through an oestrogen receptor mediated mechanism. Br J Cancer 67 5 (1993) 945-952
44. Jordan V.C., Jeng M.H., Catherino W.H., and Parker C.J. The estrogenic activity of synthetic progestins used in oral contraceptives. Cancer 71 4 Suppl (1993) 1501-1505
45. Jeng M.H., Parker C.J., and Jordan V.C. Estrogenic potential of progestins in oral contraceptives to stimulate human breast cancer cell proliferation. Cancer Res 52 23 (1992) 6539-6546
46. Wiebe J.P., Muzia D., Hu J., Szwajcer D., Hill S.A., and Seachrist J.L. The 4-pregnene and 5-alpha-pregnane progesterone metabolites formed in nontumorous and tumorous breast tissue have opposite effects on breast cell proliferation and adhesion. Cancer Res 60 4 (2000) 936-943
47. Tsai M.J., and O'Malley B.W. Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu Rev Biochem 63 (1994) 451-486
48. Mosselman S., Polman J., and Dijkema R. ER beta: identification and characterization of a novel human estrogen receptor. FEBS Lett 392 1 (1996) 49-53
49. Kuiper G.G., Enmark E., Pelto-Huikko M., Nilsson S., and Gustafsson J.A. Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 93 12 (1996) 5925-5930
50. Kuiper G.G., Carlsson B., Grandien K., et al. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 138 3 (1997) 863-870
51. Clarke R.B., Howell A., Potten C.S., and Anderson E. Dissociation between steroid receptor expression and cell proliferation in the human breast. Cancer Res 57 22 (1997) 4987-4991
52. Jarvinen T.A., Pelto-Huikko M., Holli K., and Isola J. Estrogen receptor beta is coexpressed with ERalpha and PR and associated with nodal status, grade, and proliferation rate in breast cancer. Am J Pathol 156 1 (2000) 29-35
53. Roger P., Sahla M.E., Makela S., Gustafsson J.A., Baldet P., and Rochefort H. Decreased expression of estrogen receptor beta protein in proliferative preinvasive mammary tumors. Cancer Res 61 6 (2001) 2537-2541
54. Speirs V., Skliris G.P., Burdall S.E., and Carder P.J. Distinct expression patterns of ER alpha and ER beta in normal human mammary gland. J Clin Pathol 55 5 (2002) 371-374
55. Graham J.D., and Clarke C.L. Expression and transcriptional activity of progesterone receptor A and progesterone receptor B in mammalian cells. Breast Cancer Res 4 5 (2002) 187-190
56. Mote P.A., Bartow S., Tran N., and Clarke C.L. Loss of co-ordinate expression of progesterone receptors A and B is an early event in breast carcinogenesis. Breast Cancer Res Treat 72 2 (2002) 163-172
57. Ricketts D., Turnbull L., Ryall G., et al. Estrogen and progesterone receptors in the normal female breast. Cancer Res 51 7 (1991) 1817-1822
58. Shoker B.S., Jarvis C., Sibson D.R., Walker C., and Sloane J.P. Oestrogen receptor expression in the normal and pre-cancerous breast. J Pathol 188 3 (1999) 237-244
59. Seagroves T.N., Lydon J.P., Hovey R.C., Vonderhaar B.K., and Rosen J.M. C/EBPbeta (CCAAT/enhancer binding protein) controls cell fate determination during mammary gland development. Mol Endocrinol 14 3 (2000) 359-368
60. Russo J., Ao X., Grill C., and Russo I.H. Pattern of distribution of cells positive for estrogen receptor alpha and progesterone receptor in relation to proliferating cells in the mammary gland. Breast Cancer Res Treat 53 3 (1999) 217-227
61. Zeps N., Bentel J.M., Papadimitriou J.M., D'Antuono M.F., and Dawkins H.J. Estrogen receptor-negative epithelial cells in mouse mammary gland development and growth. Differentiation 62 5 (1998) 221-226
62. Capuco A.V., Ellis S., Wood D.L., Akers R.M., and Garrett W. Postnatal mammary ductal growth: three-dimensional imaging of cell proliferation, effects of estrogen treatment, and expression of steroid receptors in prepubertal calves. Tissue Cell 34 3 (2002) 143-154
63. Mallepell S., Krust A., Chambon P., and Brisken C. Paracrine signaling through the epithelial estrogen receptor {alpha} is required for proliferation and morphogenesis in the mammary gland. Proc Natl Acad Sci USA (2006)
64. Wilson C.L., Sims A.H., Howell A., Miller C.J., and Clarke R.B. Effects of oestrogen on gene expression in epithelium and stroma of normal human breast tissue. Endocrine-Related Cancer 13 (2006) 617-628
65. Shoker B.S., Jarvis C., Clarke R.B., et al. Estrogen receptor-positive proliferating cells in the normal and precancerous breast. Am J Pathol 155 6 (1999) 1811-1815
66. Clarke R.B., Anderson E., Howell A., and Potten C.S. Regulation of human breast epithelial stem cells. Cell Prolif 36 Suppl 1 (2003) 45-58
67. Clarke R.B., Spence K., Anderson E., Howell A., Okano H., and Potten C.S. A putative human breast stem cell population is enriched for steroid receptor-positive cells. Dev Biol 277 2 (2005) 443-456
68. Welm B.E., Tepera S.B., Venezia T., Graubert T.A., Rosen J.M., and Goodell M.A. Sca-1(pos) cells in the mouse mammary gland represent an enriched progenitor cell population. Dev Biol 245 1 (2002) 42-56
69. Bocker W., Moll R., Poremba C., et al. Common adult stem cells in the human breast give rise to glandular and myoepithelial cell lineages: a new cell biological concept. Lab Invest 82 6 (2002) 737-746
70. Gudjonsson T., Villadsen R., Nielsen H.L., Ronnov-Jessen L., Bissell M.J., and Petersen O.W. Isolation, immortalization, and characterization of a human breast epithelial cell line with stem cell properties. Genes Dev 16 6 (2002) 693-706
71. Shackleton M., Vaillant F., Simpson K.J., et al. Generation of a functional mammary gland from a single stem cell. Nature 439 7072 (2006) 84-88
72. Stingl J., Eirew P., Ricketson I., et al. Purification and unique properties of mammary epithelial stem cells. Nature (2006)
73. Stingl J., Eaves C.J., Zandieh I., and Emerman J.T. Characterization of bipotent mammary epithelial progenitor cells in normal adult human breast tissue. Breast Cancer Res Treat 67 2 (2001) 93-109
74. Clayton H., Titley I., and Vivanco M. Growth and differentiation of progenitor/stem cells derived from the human mammary gland. Exp Cell Res 297 2 (2004) 444-460
75. Alvi A.J., Clayton H., Joshi C., et al. Functional and molecular characterisation of mammary side population cells. Breast Cancer Res 5 1 (2003) R1-R8
76. Zeps N., Dawkins H.J., Papadimitriou J.M., Redmond S.L., and Walters M.I. Detection of a population of long-lived cells in mammary epithelium of the mouse. Cell Tissue Res 286 3 (1996) 525-536
77. Smith G.H. Label-retaining epithelial cells in mouse mammary gland divide asymmetrically and retain their template DNA strands. Development 132 4 (2005) 681-687
78. Dontu G., El-Ashry D., and Wicha M.S. Breast cancer, stem/progenitor cells and the estrogen receptor. Trends Endocrinol Metab 15 5 (2004) 193-197